Scott Myers

Insider Reports History

Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Signature
Scott Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Myers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Common Stock 260K $5.45M $21.00 Apr 12, 2023 Direct
Zentalis Pharmaceuticals, Inc. Director Common Stock 339K $403K $1.19 Jun 17, 2025 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 35K $379K $10.82 Aug 22, 2025 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 28.5K Jun 11, 2025 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.79 Nov 13, 2023 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 Mar 11, 2024 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Scott Myers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DVAX DYNAVAX TECHNOLOGIES CORP Aug 22, 2025 1 $41.1K 4 Aug 25, 2025 Director
ZNTL Zentalis Pharmaceuticals, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
DVAX DYNAVAX TECHNOLOGIES CORP Jun 11, 2025 2 $0 4 Jun 13, 2025 Director
ZNTL Zentalis Pharmaceuticals, Inc. Apr 30, 2025 1 $29.4K 4 Apr 30, 2025 Director
ZNTL Zentalis Pharmaceuticals, Inc. Nov 13, 2024 1 $0 4 Nov 13, 2024 Director
ZNTL Zentalis Pharmaceuticals, Inc. Nov 13, 2024 0 $0 3 Nov 13, 2024 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 23, 2024 2 $0 4 May 28, 2024 Director
HARP Harpoon Therapeutics, Inc. Mar 11, 2024 3 $0 4 Mar 11, 2024 Director
HARP Harpoon Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 5 -$81.4K 4 Nov 15, 2023 Director
HARP Harpoon Therapeutics, Inc. Oct 1, 2023 1 $0 4 Oct 2, 2023 Director
HARP Harpoon Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 6, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2023 2 $0 4 May 31, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Apr 12, 2023 1 $101K 4 Apr 12, 2023 Chief Executive Officer, Director
HARP Harpoon Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Mar 13, 2023 1 $160K 4 Mar 13, 2023 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 6, 2023 2 $0 4 Feb 7, 2023 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 6, 2023 0 $0 3 Feb 7, 2023 Chief Executive Officer, Director
SELB SELECTA BIOSCIENCES INC Jan 2, 2023 1 $0 4 Jan 4, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2022 2 $0 4 May 27, 2022 Director
SELB SELECTA BIOSCIENCES INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Director
HARP Harpoon Therapeutics, Inc. Oct 25, 2021 1 $0 4 Oct 26, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Oct 19, 2021 2 $0 4 Oct 21, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Oct 19, 2021 0 $0 3 Oct 21, 2021 Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 1 $0 4/A May 14, 2021 Director